BREAKING
Fiserv (FISV) Earnings: 4Q25 Key Numbers 56 minutes ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 56 minutes ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 2 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 14 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 19 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 23 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago
ADVERTISEMENT
Market News

Constellation Brands (STZ): The hits and misses from the Q2 earnings report

Shares of Constellation Brands Inc. (NYSE: STZ) stayed in red territory on Wednesday after the company delivered mixed results for the second quarter of 2022. A revenue beat and raised guidance barely made up for the miss on earnings. Here are the hits and misses from the earnings report: Hits Revenue beat Net sales rose […]

$STZ October 6, 2021 3 min read

Shares of Constellation Brands Inc. (NYSE: STZ) stayed in red territory on Wednesday after the company delivered mixed results for the second quarter of 2022. A revenue beat and raised guidance barely made up for the miss on earnings. Here are the hits and misses from the earnings report:

Hits

Revenue beat

Net sales rose 5% year-over-year to $2.37 billion in Q2, helped by double-digit sales growth in the Beer business and strong organic sales growth in the Wines and Spirits segment. The top line beat market estimates.

Guidance increase

Constellation raised its FY2022 comparable EPS outlook to a range of $10.15-10.45 compared to the previous range of $10.00-10.30. The company now expects net sales within the Beer segment to increase 9-11% for the year versus the previous range of 7-9%. Organic net sales in the Wine and Spirits segment is expected to grow 2-4%.

ADVERTISEMENT

Strong Beer results

Net sales in the Beer segment increased 14% YoY to $1.86 billion in Q2. Depletion volume growth was over 7%, driven by strong performances from Modelo Especial and Corona Extra. Depletion volume growth was 16% for Modelo Especial and around 5% for Corona Extra. Shipment volume increased 11.7% in the quarter. For FY2022, operating income in the Beer segment is estimated to increase 4-6%.

Constellation expects the strong demand for the Modelo Especial, Corona Extra and Pacifico brands to continue for the foreseeable future. The company is seeing a steady rise in household penetration for Modelo Especial and expects to see continued growth for this brand.

Misses

Earnings miss

For the second quarter of 2022, Constellation reported comparable EPS of $2.38, which was down 14% year-over-year and below analysts’ projections.

ADVERTISEMENT

Wine and Spirits

Reported net sales fell 18% YoY to $509.8 million in the second quarter. Shipment volume was down 36.2% and depletion volume dropped 2.3%. Shipments and depletions were negatively impacted by port delays for international brands as well as route to market changes. Depletions were also affected by the challenging overlap in consumer pantry loading behavior, especially for mainstream brands which saw good growth during the pandemic.  

On an organic basis, however, the wine segment delivered net sales growth of 15% and shipment volume growth of 5.7%. This growth was driven by strong performances within The Prisoner Brand Family, Kim Crawford and Meiomi.

For FY2022, Constellation expects net sales in this segment to decline 22-24% and operating income to decrease 23-25%.

Click here to access the full transcript of Constellation Brands’ Q2 2022 earnings conference call

ADVERTISEMENT
ADVERTISEMENT